Location History:
- Fujian, CN (2019)
- Xiamen, CN (2022)
Company Filing History:
Years Active: 2019-2022
Title: Yan Liu: Innovator in Pharmaceutical Compounds
Introduction
Yan Liu is a notable inventor based in Xiamen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds aimed at treating tumors. With a total of 2 patents, his work reflects a commitment to advancing medical science.
Latest Patents
Yan Liu's latest patents include groundbreaking inventions such as substituted penta-fused hexa-heterocyclic compounds. These compounds exhibit selective inhibition for PIKfyve kinase and are designed for use in medications that prevent or treat diseases associated with PIKfyve, particularly in the context of tumor growth and metastasis. Another significant patent involves pyrimidopyrrole compounds, which are also aimed at preventing and treating tumors. This invention includes a method for preparing these compounds and their pharmaceutical compositions.
Career Highlights
Throughout his career, Yan Liu has worked with esteemed institutions such as Xiamen University and Seinda Pharmaceutical Guangzhou Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical research.
Collaborations
Yan Liu has collaborated with notable colleagues, including Xianming Deng and Ting Zhang, who have contributed to his research endeavors. Their combined expertise has furthered the development of his patented compounds.
Conclusion
Yan Liu's contributions to pharmaceutical innovations demonstrate his dedication to improving medical treatments for tumor-related diseases. His patents reflect a significant advancement in the field, showcasing the potential for new therapeutic options.